MMP9 and infarction: In the initial phase of AIS, elevated neutrophil counts were linked to greater infarction size, suggesting that the rise in neutrophil levels may worsen blood–brain barrier damage by facilitating excessive matrix metalloproteinase-9 expression [62, 63].